Member Info for Drew57

Not all sells. 30k shares is my top up

Am I?? Or is silver up more than 5%?

If you want something different to this great divi payer:

No dividend whatsoever

Up 9% in the last month

Up 21% in the last 6 months

Up 41% in the last year

I have kept buying and will continue in the medium term

You've guessed it -

GOLD

IMO DYOR

Please excuse O/T

Dallo, what do you make of today's action on ENET?

Reason for sudden rise?

You must be the 'special one' SteveJ.

Your post gets the SP to 5 decimal places!

Just seen the item on ITV lunchtime news and waited in vain for even a passing mention of Scancell. It was if the NHS had done it all themselves.

As a newish investor here what exactly does "capital not deployed on strain" mean?

Tubby, or not tubby; that is the question

Rats - 'astute' quote from the New Testament there. We hope the "wailing and gnashing of teeth" is imminent.

NAV up 13.8% - looks good at first view.

Hi moonparty,

>> For non-techies, a google is 1 followed by 100 zeros.

Actually, that's a Googol, different thing altogether :-)

Zac, I cannot find L&G International Index Trust on here when I search under Legal. What is the ticker?

Nonsense. If you held the shares at the close of the day before ex-div you will get the dividend.

I wonder how important Suez canal revenues are to the Egyptian economy. They must be badly hit by the diversion of shipping round the Cape.

Thanks for feedback. It just seemed quite a large rise for this share without specific news.

"Undervalued" - agreed. We were nearly 300p 12 months ago and nothing much negative happened since.

Dallo; any ideas to explain today's rise?

Those put options are beginning to look like a good plan. Gold has dropped well below 1900 in the last few days. Is it just inflation to blame?

Dozens of small trades all shown at the exact same time??

Has anyone mentioned this yet?

"We are delighted to welcome Sath Nirmalananthan as Chief Financial Officer.

Sath is an experienced finance professional with over 15 years of experience across healthcare in FTSE and NASDAQ listed companies, investment banking, and audit. Before joining Scancell, Sath was Chief Financial Officer for Europe, Middle-East, and Africa at Prenetics and has held senior positions at BTG plc. He is also a Non-Executive member of the audit committee at the Institute of Cancer Research (ICR).

To learn more, read the full release here: https://lnkd.in/e3YRrnDW"

https://www.linkedin.com/feed/update/urn:li:activity:7102227888304705536/